Evidence map›Paper›PMID 38468698›Full record

ArticleClinical kidney journal2024

Association between diabetic status and risk of all-cause and cause-specific mortality on dialysis following first kidney allograft loss.

Amali Samarasinghe, Germaine Wong, Armando Teixeira-Pinto, David W Johnson, Carmel Hawley, Helen Pilmore, William R Mulley, Matthew A Roberts, Kevan R Polkinghorne, Neil Boudville and 6 more

Open access · goldAbstract read
In one paragraph

Article in Clinical kidney journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Prognostic impact of post-transplant diabetes mellitus in kidney allograft recipients: a meta-analysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 3 countries.

Amali SamarasingheDepartment of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
Germaine WongSchool of Public Health, Faculty of Medicine and Health, Sydney University, Sydney, Australia.ORCID https://orcid.org/0000-0001-8422-7269
Armando Teixeira-PintoSchool of Public Health, Faculty of Medicine and Health, Sydney University, Sydney, Australia.
David W JohnsonDepartment of Kidney and Transplant Services, Princess Alexandra Hospital, Queensland, Australia.
Carmel HawleyDepartment of Kidney and Transplant Services, Princess Alexandra Hospital, Queensland, Australia.
Helen PilmoreDepartment of Renal Medicine, Auckland City Hospital, Auckland, New Zealand.
William R MulleyDepartment of Nephrology, Monash Medical Centre, Melbourne, Australia.
Matthew A RobertsEastern Health Clinical School, Monash University, Victoria, Australia.
Kevan R PolkinghorneDepartment of Nephrology and Medicine, Monash Medical Centre, Melbourne, Australia.
Neil BoudvilleDepartment of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
Christopher E DaviesFaculty of Health and Medical Science, Adelaide University Medical School, South Australia, Australia.
Andrea K ViecelliDepartment of Kidney and Transplant Services, Princess Alexandra Hospital, Queensland, Australia.
Esther OoiSchool of Biomedical Sciences, University of Western Australia, Western Australia, Australia.
Nicholas G LarkinsDepartment of Nephrology, Perth Children's Hospital, Perth, Western Australia, Australia.
Charmaine LokFaculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Wai H LimDepartment of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
The University of Western Australia · AUMonash Medical Centre · AUThe University of Sydney · AUTranslational Research Institute · AUAustralia and New Zealand Dialysis and Transplant Registry · AUEastern Health · AUSir Charles Gairdner Hospital · AUThe University of Queensland · AUUniversity Health Network · CAUniversity of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes mellitus (DM) is associated with a greater risk of mortality in kidney transplant patients, primarily driven by a greater risk of cardiovascular disease (CVD)-related mortality. However, the associations between diabetes status at time of first allograft loss and mortality on dialysis remain unknown. Methods: All patients with failed first kidney allografts transplanted in Australia and New Zealand between 2000 and 2020 were included. The associations between diabetes status at first allograft loss, all-cause and cause-specific mortality were examined using competing risk analyses, separating patients with diabetes into those with pre-transplant DM or post-transplant diabetes mellitus (PTDM). Results: Of 3782 patients with a median (IQR) follow-up duration of 2.7 (1.1-5.4) years, 539 (14%) and 390 (10%) patients had pre-transplant DM or developed PTDM, respectively. In the follow-up period, 1336 (35%) patients died, with 424 (32%), 264 (20%) and 199 (15%) deaths attributed to CVD, dialysis withdrawal and infection, respectively. Compared to patients without DM, the adjusted subdistribution HRs (95% CI) for pre-transplant DM and PTDM for all-cause mortality on dialysis were 1.47 (1.17-1.84) and 1.47 (1.23-1.76), respectively; for CVD-related mortality were 0.81 (0.51-1.29) and 1.02 (0.70-1.47), respectively; for infection-related mortality were 1.84 (1.02-3.35) and 2.70 (1.73-4.20), respectively; and for dialysis withdrawal-related mortality were 1.71 (1.05-2.77) and 1.51 (1.02-2.22), respectively. Conclusions: Patients with diabetes at the time of kidney allograft loss have a significant survival disadvantage, with the excess mortality risk attributed to infection and dialysis withdrawal.

Indexed as

allograft lossdiabetesdialysiskidney failuremortality

Identifiers

PMID38468698
PMCPMC10926326
OpenAlexW4392575113

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.